This year saw the approval of new therapies as well as the continued evolution of time-to-treat infections and updated guidelines.
SHEA Advocates for CDC Funding Amid Antimicrobial Resistance Concerns
The Latest Updates on Managing Your Patients With Antimicrobial Resistant Gram-Negative Infections
Can Daily Doxycycline Prevent STIs?
Expert Guidance on Managing Acute Bacterial Skin and Skin Structure Infections (ABSSSI) in an Outpatient Setting
Efficacy of Nasal Sprays in Respiratory Illness Management
A Pandemic Within a Pandemic: Antimicrobial Resistance During the COVID-19 Pandemic